BrightHeart
About BrightHeart
BrightHeart is a healthcare AI company specializing in the development of artificial intelligence-driven ultrasound screening software for the prenatal detection of congenital heart defects (CHDs) in fetuses. Their flagship product, the B-Right AI platform, is designed to integrate seamlessly into existing clinical workflows, providing real-time guidance to sonographers and obstetricians during fetal heart ultrasound exams. The software assists in consistently capturing the necessary anatomical views, validating exam completeness, and flagging potential morphological abnormalities suggestive of CHDs, thereby augmenting clinician capabilities and reducing the margin for error in a technically demanding area of prenatal care.
The company’s technology aims to standardize expert-level fetal heart screening, ultimately improving diagnostic accuracy and enabling earlier intervention and optimized management of pregnancies and deliveries for affected newborns. BrightHeart has secured multiple FDA clearances for its AI software, allowing for commercial deployment in the U.S. and expansion across Europe. Clinical studies have demonstrated that BrightHeart’s AI software can improve detection rates and enhance efficiency in prenatal ultrasound evaluations.
Focus Areas
Business Intelligence
| Key Investors | Odyssée Venture, GO Capital, Mussallem CHD Alliance, Lift Value, IDAHO HealthTech Club via Side Angels, Sofinnova Partners, Professor Laurent Salomon, Sacha Loiseau, John Gridley |
| Partnerships | GE HealthCare's Voluson™ Solution Store, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai Hospital/Mount Sinai West Hospital, Carnegie Imaging for Women |
| Technology | B-Right AI Platform, cloud-native, seamlessly integrates into existing ultrasound workflows as a plug-and-play solution, compatible with major ultrasound manufacturers and reporting solutions, offers automatic display on cart-side tablets and detailed assessments on a standalone web platform. Utilizes NVIDIA L4 Tensor Core GPUs in the cloud through AWS, NVIDIA CUDA Toolkit, NVIDIA cuDNN, and Meta's DINOv2 model for self-supervised learning. |
| FDA Clearances | 5 cleared products (estimated) |
What Physicians Need to Know
BrightHeart offers a powerful suite of tools designed to elevate your diagnostic capabilities in prenatal care. For obstetricians, the AI-driven screening can significantly enhance early detection of CHDs, allowing for more informed patient counseling and referral. Pediatric cardiologists will benefit from the detailed, standardized reports that streamline pre-natal consultations and post-natal care planning. The AI's ability to reduce scan times and improve accuracy can lead to better patient throughput and reduced diagnostic uncertainty. Consider how integrating this technology can optimize your workflow and improve patient outcomes by enabling earlier and more precise interventions.
BrightHeart's platform is designed for robust integration with existing Electronic Health Record (EHR) systems and Picture Archiving and Communication Systems (PACS) to ensure a seamless flow of patient data and imaging results, minimizing manual data entry and maximizing efficiency for clinical teams.
Reviews & Opinions
Videos
News, demos, and interviews about BrightHeart.
Videos load interactively. If none appear, search YouTube for BrightHeart →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded BrightHeart.
Comparisons
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]